Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
Publications
2 records shown · first 60Absence of the LRRK2 mutation in Emirati Parkinson's disease patients in contrast to other Arab populations.
PMID 41383818 | PMCID PMC12689503 | DOI 10.3389/fnagi.2025.1676115 · Frontiers in aging neuroscience · 2025 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| variant | G2019S | “CONCLUSION: The absence of the LRRK2 and specifically the G2019S mutation in Emirati PD patients corroborates findings from Saudi Arabia and indicates a distinct genetic pattern compared to other Arab regions like Egypt and Maghreb (North African) countries, where the G2019S mutation prevalence ranges from 10 to 40%.” | 0.82 | literature_variant_regex_v2 |
| gene | LRRK2 | “Absence of the LRRK2 mutation in Emirati Parkinson's disease patients in contrast to other Arab populations.” | 0.98 | hgnc_dict_v1 |
| phenotype | Parkinson disease | “Absence of the LRRK2 mutation in Emirati Parkinson's disease patients in contrast to other Arab populations.” | 0.93 | phenotype_alias_lexicon_v2 |
| population | Saudi Arabia | “RESULTS: The LRRK2 mutation was not detected in any of the 50 Emirati PD patients (mean age 64.2 ± 14.1 years, of whom 56% are male) examined. CONCLUSION: The absence of the LRRK2 and specifically the G2019S mutation in Emirati PD patients corroborates findings from Saudi Arabia and indicates a distinct genetic pattern compared to other Arab regions like Egypt and Maghreb (North African) countries, where the G2019S mutation prevalence ranges from 10 to 40%.” | 0.95 | saudi_context_rules_v1 |
Exploring the focal role of LRRK2 kinase in Parkinson's disease.
PMID 35147886 | DOI 10.1007/s11356-022-19082-5 · Environmental science and pollution research international · 2022 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| variant | G2019S | “G2019S is perhaps the maximum common mutation in PD subjects.” | 0.82 | literature_variant_regex_v2 |
| gene | LRRK2 | “Exploring the focal role of LRRK2 kinase in Parkinson's disease.” | 0.98 | hgnc_dict_v1 |
| phenotype | Parkinson disease | “Exploring the focal role of LRRK2 kinase in Parkinson's disease.” | 0.93 | phenotype_alias_lexicon_v2 |